# GPC-Rx Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gpc-rx

- Industry: Biotechnology
- Headquarters: Seattle, US
- Total disclosed funding: $4.5M
- Latest round: Series A (Nov 21, 2008)
- Investors on record: 8

## About

GPC-Rx Corporation is a US-based company that operates as a developer of G-protein coupled receptors.

## Funding rounds

- Series A, Nov 21, 2008, $4.5M — ARCH Venture Partners, OVP Venture Partners, Alexandria Venture Investments, Amgen Ventures, WRF Capital, PPD, Inc., Caltech, Accelerator Life Science Partners

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A
- OVP Venture Partners (https://capitalatlas.ai/funds/ovp-venture-partners) — Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series A
- WRF Capital (https://capitalatlas.ai/funds/wrf-capital) — Series A
- PPD, Inc. — Series A
- Caltech (https://capitalatlas.ai/funds/caltech) — Series A
- Accelerator Life Science Partners (https://capitalatlas.ai/funds/accelerator-life-science-partners) — Series A